Introduction {#Sec1}
============

Severe congenital neutropenia (SCN, also known as Kostmann disease) includes a heterogeneous group of disorders characterized by chronic low absolute neutrophil counts (ANC) (below 0.5 × 10^9^/l) in the peripheral blood, early onset of bacterial infections, and mostly a maturation arrest of the myelopoiesis in the bone marrow at the level of promyelocyte/myelocyte stage \[[@CR1]--[@CR3]\]. Recent studies have revealed that a number of inherited gene mutations may cause SCN \[[@CR4]\]. Heterozygous mutations in the *ELANE* gene (formerly named *ELA2*), encoding the neutrophil primary granule protease, neutrophil elastase, were demonstrated in approximately 50--60% of patients with SCN \[[@CR5], [@CR6]\], whereas homozygous mutations in the *HAX1* gene, encoding the mitochondrial antiapoptotic protein HS1-associating protein X-1 (HAX-1), were identified in about 15% of patients \[[@CR3]\]. In addition, around one third of the patients with SCN is still uncharacterized by any gene mutation. Cyclic neutropenia (CyN) is another hereditary form of severe chronic neutropenia in which the neutrophil count oscillates and patients present less severe clinical symptoms compared to SCN. In the majority of cases with CyN, *ELANE* mutations were determined to be responsible for the disease \[[@CR7]\].

Patients with SCN or CyN currently receive recombinant human granulocyte colony-stimulating factor (G-CSF) therapy and more than 90% of patients respond to this treatment with increased peripheral neutrophil level, diminished vulnerability to bacterial infections and much improved quality of life \[[@CR8]\]. However, there are still patients who exhibit unsatisfactory periodontal health despite having G-CSF-normalized neutrophil levels and receiving regular professional dental care \[[@CR9]--[@CR11]\].

The pathogenesis of gingivitis and periodontitis is multifactorial and includes complex interactions between oral microbes and host defense \[[@CR12]\]. Neutrophils are key immune cells for oral health and neutrophil deficiency or dysfunction often results in periodontal disease \[[@CR13]\]. Besides low levels of ANC patients with SCN also exhibit deficiencies in neutrophil granule-associated proteins, including the antimicrobial peptides pro-LL-37 (or hCAP-18) with its active peptide LL-37, and human neutrophil peptides 1--3 (HNP1--3) \[[@CR14]\]. The lack of LL-37 and/or HNP suggests that these neutrophils are functionally deficient with respect to their antimicrobial capacity. Such deficiency in periodontal neutrophils may influence the subgingival microbiota composition in the periodontal pocket, and as a consequence, contribute to the pathogenesis of periodontal breakdown.

Although it has long been recognized that patients with SCN or CyN often suffer from early onset of severe periodontitis \[[@CR15]--[@CR19]\], the correlation between genotype and phenotype in terms of gene mutations in SCN and periodontal health is still unclear. Previous studies have demonstrated that *ELANE* mutations correlate with more severe disease manifestation in patients with SCN \[[@CR20]\], and that patients with *ELANE* mutations require higher doses of G-CSF compared to patients with *HAX1* mutations \[[@CR3]\]. In light of these findings, we hereby address the hypothesis that *ELANE* gene mutations are associated with the occurrence of periodontitis in subjects with SCN. The underlying parameters that are believed to contribute to periodontitis were studied, including subgingival microbiota composition, proinflammatory cytokines, as well as innate immune components HNP1--3 and pro-LL-37/LL-37.

Materials and Methods {#Sec2}
=====================

Participants {#Sec3}
------------

From 2006 to 2008, patients with SCN (*n* = 13) or CyN (*n* = 1) were recruited from Karolinska University Hospital, Sweden and numbered periodontitis--neutropenia (PN) 1-to-14 according to recruitment date. The subjects ranged in age from 6 to 50 years with various forms of SCN or CyN. Ethical permission was granted by the local ethical committee at Karolinska University Hospital (2006/176-31/4). All subjects or their parents provided informed consent before participating in this study.

Clinical Examination {#Sec4}
--------------------

The clinical examination involved recording visible plaque index (%), bleeding on probing (BOP, %), probing depth (mm), and radiographs which were taken in order to determine the occurrence of alveolar bone loss. The distance between enamel cement junction and marginal bone (mm) was measured on the radiographs and alveolar bone loss was diagnosed when the distance exceeded 3.0 mm. Based on the clinical examination, the patients were categorized as either being healthy, suffering from gingivitis or periodontitis, or edentulous, respectively. Gingivitis was diagnosed when BOP exceeded 25%, while periodontitis was diagnosed when the patient exhibited both alveolar bone loss for more than three teeth and periodontal pockets exceeding 4 mm for the same teeth.

Plasma, GCF, and Subgingival Bacteria Sampling {#Sec5}
----------------------------------------------

Peripheral blood was collected and coagulation was inhibited using EDTA. Following centrifugation, plasma was gathered from the top layer and subsequently stored at −80°C in aliquots.

For each subject, GCF was collected from the mesial surface of an incisor or for PN2 from a deciduous molar by inserting a paper strip (PerioPaper, Oralflow Inc.) into the gingival sulcus for 15 s. The strip was then analyzed using a Periotron Model 8000 (Oralflow Inc.), and the volume was calculated by interpolation from a standard curve. The two edentulous patients (PN4 and PN9) did not provide GCF samples. Individual strips were then placed into a sterile tube containing 120 μl PBS buffer (pH = 6.8), 0.01 M EDTA, 0.3% bovine globulin, 0.005% Triton X-100, and 0.05% sodium azide. The samples were then stored at −80°C.

Subgingival bacteria samples were collected using a paper strip from the distal surface of an incisor or from a deciduous molar for PN2. Since there was lack of data and references in the literature regarding the subgingival microbiota assessed using 454 pyrosequencing, we collected subgingival bacterial samples from nine systemically healthy individuals aged from 5 to 19 years, with three samples from sites of periodontitis and six from healthy sites or those of gingivitis, in order to provide references for samples from neutropenic cases in the 454 analysis. After collection, all samples were stored at −80°C until analysis.

Luminex Cytokine Immunoassay {#Sec6}
----------------------------

Plasma and GCF samples were analyzed for IL-1β, IL-4, IL-6, IL-17, IFN-γ, and TNF-α concentrations using fluorescent bead-based Luminex cytokine immunoassays, which were performed using the Bio-Plex system (Bio-Rad laboratories). Samples were thawed on ice and homogenized in a vortex mixer for 1 min before analysis. The cytokine concentrations were determined using a human cytokine LINCOplex kit (Millipore) according to the manufacturer's instructions and were expressed as ng/ml in GCF and pg/ml in plasma.

Gel Electrophoresis and Immunoblotting {#Sec7}
--------------------------------------

Plasma and GCF samples were analyzed for pro-LL-37 and mature LL-37 peptide content using Western blotting. GCF samples were further tested for HNP1--3 using the same method. The GCF samples were treated with 60% acetonitrile containing 1% trifluoroacetic acid for 2 h on a shaker at 4°C to extract small peptides from the periopaper. Following centrifugation, the extraction supernatant was then transferred into a sterile tube, kept at −80°C, and lyophilized until dry. The GCF extract and plasma were dissolved in NuPAGE SDS sample buffer (Invitrogen) and electrophoresed in 1.0 mm 4--12% NuPAGE Bis--Tris gels (Invitrogen) under reducing conditions. Immunoblotting was performed as previously described \[[@CR21]\] using the following antibodies: rabbit anti-LL-37 (Innovagen, Sweden), mouse anti-alpha defensin 1+2+3 antibody (Abcam), goat anti-rabbit, and goat anti-mouse immunoglobulins (Dako, Denmark). Detection was carried out using chemiluminescence (SuperSignal West Pico, Pierce).

454 Pyrosequencing {#Sec8}
------------------

The microbiota of subgingival bacterial samples from the patients and reference individuals was analyzed using a 454 FLX pyrosequencing facility according to previously described methods with minor modifications \[[@CR22], [@CR23]\]. Briefly, DNA extraction was performed using DNeasy Blood and Tissue kit (Qiagen) with proteinase K treatment at 56°C for 16 h. For each extracted DNA sample, three 50 μl PCR mixes were prepared containing 1× PCR buffer, 200 μM dNTP PurePeak DNA Polymerization Mix (Pierce Nucleic Acid Technologies), 0.5 μM of each primer, 0.5 U Phusion F-530L enzyme (Finnzyme), and 2 μl template-DNA. The primer pairs, amplifying the hypervariable 16s rRNA gene V3-V4 regions, were: 341f (5′ CCTACGGGNGGCWGCAG) with adaptor B and 805r (5′ GACTACHVGGGTATCTAATCC) with adaptor A and a sample-specific sequence barcode. The PCR conditions were 95°C for 5 min, 26 cycles of 95°C for 40 s, 58°C for 40 s, and 72°C for 1 min, followed by 72°C for 7 min. A PCR reaction without template was also used as a control for each primer pair. After analyses in agarose gel (1% *w*/*v* in TBE buffer), the samples with the same barcode were pooled and PCR reactions were purified using an Agencourt AMPure system (Beckman Coulter Genomics). The DNA concentrations were measured using Qubit (Invitrogen), and the quality control was performed with a Bioanalyzer 2100 using the DNA 1000 chip (Agilent Technologies). The samples were diluted to 3 ng/μl, and 5 μl of each sample was pooled. Region V4 was sequenced using 454 pyrosequencing with a standard amplicon kit and run in the 454-FLX (Roche, Switzerland) \[[@CR24]\].

Sequences were excluded if there was no perfect match with the primer or barcode, ambiguous nucleotides, or the sequence was shorter than 200 nucleotides excluding the primer/barcode. Non-redundant reads with the primer/barcode removed were aligned and sorted into operational taxonomic units (OTU) using complete linkage clustering and a 3% distance threshold, which was performed using the Pyrosequencing Pipeline at Ribosomal Database Project (RDP) \[[@CR25]\]. 16S rRNA gene sequences from RDP 10.22 were converted into a local BLAST database. The OTUs were BLAST searched against the database with a 95% identity threshold over at least 180 nucleotides. Different OTU hits were sorted to the taxonomic level for further analysis.

The different sequence identification levels were analyzed and visualized with regards to relative abundance as a heat map using MultiEperiment Viewer v4.6 software \[[@CR26]\]. Principal coordinate analysis (PCoA) was performed and visualized in Fast Unifrac (<http://bmf.colorado.edu/fastunifrac/>) \[[@CR27]\] using normalized weighted abundance. The Shannon diversity index was calculated using the R package vegan (<http://CRAN.R-project.org/package=vegan>) for each sample, and the significance was tested using the Wilcoxon rank sum test.

Results {#Sec9}
=======

Clinical Findings {#Sec10}
-----------------

The medical history of the patients (*n* = 14) is presented in Table [I](#Tab1){ref-type="table"}. All patients except PN14 were diagnosed before 1 1/2 years of age. Of all the patients with SCN, six exhibited *ELANE* mutations, four *HAX1* mutations, and three unknown mutation(s). Two patients (PN8 and PN9) had received HSCT before they were recruited into the study, and three patients (PN7, PN8, and PN9) had not received G-CSF treatment by the time the clinical examinations were performed. Table IMedical background of the patients with congenital neutropeniaSubjectsAgeSexDiagnosisGene mutationAge at diagnosisANC^c^ (×10^9^/L)G-CSF/Duration^d^/Dose (μg/kg/day)Other important clinical findings*ELANEHAX1*PN114MSCND89Hwt4 months2.1Yes/Since diagnosis/7.8Bronchial asthmaPN26MSCNC122Swt1 week0.9Yes/Since diagnosis/25G-CSF resistant; T-S prophylaxisPN317MSCNC26Swt1 week0.5Yes/Since 1991/5.0T-S prophylaxisPN450FSCNC26Swt3 weeks0.5Yes/Since 1991/2.5PN519FSCNC26Swt3 months0.2Yes/Since 1991/4.5Atopic dermatitisPN617MSCNwtW44X1 1/2 years1.5Yes/Since diagnosis/4.3Ureter reflux and kidney infectionPN714MSCNwtQ190X and E31KfsX54^b^2 months1.0NoPN823MSCN (HSCT^a^)wtQ190X2 months1.7NoHSCT at 7 months of age; Epilepsy; ADHDPN931FSCN (HSCT^a^)L92Hwt2 weeks3.1NoDeveloped G-CSFR mutations; HSCT 2004PN1021FCyNwtwt11 months9.2SporadicallyPN1119FSCNwtQ190X13 months7.0Yes/Since 1991/3.0Developed G-CSFR mutations; EpilepsyPN128MSCNwtwt14 months1.6Yes/Since diagnosis/9.0Motor proficiency difficultiesPN1317MSCNwtwt1 year5.7Yes/Since diagnosis/4.2Special school; SplenomegalyPN1427FSCNwtwt5 years1.2Yes/Since 1991/1.5*PN* periodontitis--neutropenia, *wt* wildtype, *T-S* trimethoprim--sulfamethoxazole, *G-CSFR* G-CSF receptor, *ADHD* attention deficit hyperactivity disorder^a^HSCT before participating in this study. PN8 had mixed chimerism and had been treated with low dose (0.5 μg/kg/day) of G-CSF until adult age; PN9 had 100% donor and normal ANC^b^Compound heterozygous *HAX1* (*cHAX1*) mutations \[[@CR61]\]^c^Reference range is 2.0--8.0^d^G-CSF treatment started in Sweden in 1991

The periodontal conditions of the patients are described in Table [II](#Tab2){ref-type="table"}. Except for PN4 and PN9 who were edentulous and PN11 who underwent professional dental care 1 year previously, the other patients had had a last dental visit between 2-to-6 months prior to the clinical examination. Their toothbrushing habits were at least once per day. Of all the patients with SCN, four were classified as being periodontally healthy, two as having gingivitis, five as having periodontitis, and two subjects as edentulous due to periodontitis at an early age. Of the six patients with *ELANE* mutations, five were diagnosed with periodontitis or edentulous. Conversely, within SCN cases, the subjects with *HAX1* or unknown mutations were mostly (six out of seven) classified as being healthy or having gingivitis. *ELANE* mutations are significantly correlated with the occurrence of periodontitis/edentulism compared to *HAX1* or unknown mutations (*P* = 0.025; Table [III](#Tab3){ref-type="table"}). The single patient with CyN displayed a healthy periodontium. Table IIPeriodontal status of the patients with congenital neutropeniaSubjectsGene mutationFull mouthPeriodontal statusTested site*ELANEHAX1*VPI (%)BOP (%)PD \> 4 mmToothPD (mm)ECJ-MB (mm)PN1D89Hwt\>50\>50NoGingivitis41, 3132PN2C122Swt\>50\>50YesPeriodontitis55, 854, 34, 3PN3C26Swt\>50\>50YesPeriodontitis41, 3169PN4C26Swt------Edentulous------PN5C26Swt\>50\>50YesPeriodontitis41, 3165PN6wtW44X\>50\>50YesPeriodontitis41, 3143.5PN7wtQ190X and E31KfsX54\<150NoHealthy41, 3122PN8wtQ190X\<25\<15NoHealthy41, 3121.5PN9L92Hwt------Edentulous------PN10wtwt\<15\<15NoHealthy41, 3122PN11wtQ190X00NoHealthy41, 3121.2PN12wtwt\<15\<15NoHealthy41, 3122PN13wtwt\>50\>50YesPeriodontitis41, 3143.5PN14wtwt\<25\>25YesGingivitis41, 3132.5*PN* periodontitis--neutropenia, *wt* wildtype, *VPI* visible plaque index, *BOP* bleeding on probing, *PD* probing depth, *ECJ-MB* enamel cement junction--marginal boneSubgingival microbiota analysis from tooth 41, or from tooth 55 in PN2; cytokine and AMP analysis from tooth 31, or from tooth 85 in PN2Table IIIPeriodontal status of patients with SCN harboring different genetic mutationsVariables*ELANE* mutations (*n* = 6)*HAX1* or unknown mutations (*n* = 7)*P* valueReceiving G-CSF55Periodontal statusHealthy04Gingivitis11Periodontitis/edentulous^a^520.025^ba^Due to periodontitis^b^Spearman correlation test

Antimicrobial Peptide and Cytokine Levels in GCF and Plasma {#Sec11}
-----------------------------------------------------------

Subjects who had received HSCT and the edentulous patients (*n* = 3) were excluded from the GCF analysis. HSCT-transplanted patients (*n* = 2) were excluded from the plasma analysis.

Neither ANC (*P* = 0.116), plasma pro-LL-37 (*P* = 0.106), GCF α-defensin (*P* = 0.703), or GCF pro-LL-37/LL-37 (*P* = 0.450) levels were significantly different in patients with *ELANE* mutations compared to *HAX1* or unknown mutations. However, an interesting observation was that patients with unknown gene etiology exhibited low levels of both HNP1--3 and LL-37, maybe reflecting a similar gene defect. The LL-37 levels in all but one patient with SCN were 10-to-1,000-fold lower than in those two patients (PN8 and PN10) that exhibited normal ANC levels without G-CSF treatment at the time of sampling (Tables [I](#Tab1){ref-type="table"} and [IV](#Tab4){ref-type="table"}). Table IVAntimicrobial peptides in GCF and plasma from patients^a^DiagnosisGene mutationSubjectsPeriodontal statusGCF HNP1--3 (μg/ml)GCF pro-LL-37 and LL-37^c^Plasma pro-LL-37 ^c,\ d^SCN*ELANE*PN1Gingivitis1920.250.01PN2Periodontitis4280.82\<0.01PN3Periodontitis\<410.56\<0.01PN5Periodontitis\<40.05\<0.01*HAX1*PN6Periodontitis406.210.03PN7Healthy\<46.93\<0.01PN11Healthy24778.180.17unknownPN12Healthy50.080.06PN13Periodontitis40.380.10PN14Gingivitis40.130.09SCN (HSCT^b^)*HAX1*PN8Healthy840324.00.31CyNunknownPN10Healthy227132.80.54*PN* periodontitis--neutropenia^a^Two edentulous patients were excluded^b^HSCT before participating in this study^c^Relative to reference plasma^d^Range in healthy individuals is 0.35--1.5

In addition, the level of IL-1β (*P* = 0.038) in GCF was significantly higher in the *ELANE* mutation group compared to *HAX1* or unknown mutation group (Table [V](#Tab5){ref-type="table"}). Although the levels of IL-17, IL-6, and TNF-α were not statistically different in the GCF, it may be noted that mean and median values in *ELANE* mutation group are higher than in *HAX1* or unknown mutation group. The GCF cytokine levels of IFN-γ and IL-4 were both below the detection limit in all samples. Moreover, there was no significant difference in terms of the cytokine levels in plasma between the two subgroups of patients. Table VCytokines in GCF from patients with SCN harboring different genetic mutationsCytokines (ng/ml)*ELANE* mutations (*n* = 5)*HAX1* or unknown mutations (*n* = 6)*P* value^a^MedianMean ± SDMedianMean ± SDIL-1β9.313.1 ± 9.32.95.1 ± 6.80.038IL-170.50.5 ± 0.40.10.2 ± 0.10.131IL-63.03.8 ± 3.80.80.8 ± 0.50.186TNF-α0.50.5 ± 0.40.010.03 ± 0.050.089^a^Mann--Whitney test

Subgingival Microflora {#Sec12}
----------------------

We generated 8,810 high-quality 16S rRNA gene sequences from 12 subgingival bacterial samples (PN4 and PN10 were excluded due to edentulism). The sequences represented seven major phyla: Actinobacteria (19.5%), Bacteroidetes (19.5%), Firmicutes (22.2%), Fusobacteria (16.6%), Proteobacteria (15.9%), Spirochaetes (2.0%), and candidate domain TM7 (1.3%). The predominant genera were *Fusobacterium*, *Streptococcus*, *Rothia*, *Prevotella*, *Corynebacterium*, *Neisseria*, *Veillonella*, *Capnocytophaga*, and *Leptotrichia*, which in total accounted for 66% of all sequences. The Shannon diversity index was similar in patients with *ELANE* mutations and *HAX1* or unknown mutations according to Wilcoxon rank sum test (*P* = 0.788). To illustrate subgingival microbiota composition of individuals, a heat map was generated to reveal the abundance of different taxa in samples from both patients with neutropenia and references (Fig. [1](#Fig1){ref-type="fig"}). A sample tree was also created using hierarchical clustering using Pearson correlation of absolute distance and complete linkage clustering (Fig. [1](#Fig1){ref-type="fig"}). In both hierarchical clustering and UniFrac PCoA (Fig. [2](#Fig2){ref-type="fig"}), three out of four samples from patients with *ELANE* mutations were clustered together with all reference samples of periodontitis. Fig. 2Principal coordinate analysis (PCoA) of microbiota in individual subjects using 1% distance threshold with normalized weighted abundance. The scatterplots are for the first two principal components (PC1 and PC2); each *point* represents a sample. PN8 is stem cell transplanted. *R* represents reference samples and patient PN10 (CyN)Fig. 1Individual subgingival microbiota composition. The heat map depicts the abundance of the different taxa in individual subgingival samples. The color scale of relative abundance ranges from 0% (*black*) to 30% (*red*). The phylum level is shown on the left-hand side. The dominant taxa (genus level, except TM7) are displayed according to the relative abundance per sample. The sample tree was generated using hierarchical clustering with Pearson correlation of absolute distance and complete linkage clustering. PN8 is stem cell transplanted. *R* represents reference samples and patient PN10 (CyN)

Discussion {#Sec13}
==========

Although the prognosis and quality of life of patients with congenital neutropenia were improved dramatically following the introduction of G-CSF therapy 20 years ago \[[@CR28]\], some patients still suffer from frequent periodontal infections despite efficient and adequate oral hygiene. In the current study, we demonstrate for the first time a link between mutations affecting *ELANE* encoding neutrophil elastase and the occurrence of periodontitis.

The periodontal condition of the patients in the present study varied from healthy to severe periodontitis and two patients were edentulous due to periodontitis, indicating great variation of the chronic inflammatory response in the periodontium among patients with congenital neutropenia. Recent genetic studies have identified multiple gene mutations in SCN, with the most common mutations affecting the *ELANE* (*ELA2*) gene. To date, more than 45 distinct *ELANE* mutations have been described in SCN and CyN \[[@CR29]\]. Our current findings demonstrate a correlation between *ELANE* mutations and periodontitis in patients with SCN, concurring with the view that *ELANE* mutations are correlated with more severe disease manifestations and having a relatively poorer response to G-CSF treatment \[[@CR3], [@CR20]\]. However, the number of patients in our study is limited since SCN is a rare disease. Further investigation involving a larger cohort will be needed to confirm our findings.

Many of the patients with *ELANE* mutations had low ANC and therefore may be expected to have more severe periodontal disease. However, it is both neutrophil functionality and neutrophil counts over time that can affect the outcome of periodontal disease. Moreover, factors such as oral hygiene and diet may influence the outcome of oral health, which we have attempted to account for by using questionnaires for patients and their dentists.

The antimicrobial peptides HNP1--3 and LL-37 are produced during neutrophil maturation in the bone marrow and are stored as pro-peptides in neutrophil granules. The pro-LL-37 (hCAP18) is also detectable in plasma from healthy individuals \[[@CR30]\]. We previously demonstrated that plasma pro-LL-37 levels were low in patients with SCN in spite of G-CSF elevated neutrophil levels, thus reflecting impaired neutrophil development \[[@CR21], [@CR31]\]. In the current study, pro-LL-37 levels in plasma were low in all patients with SCN and did not differ between the *ELANE* mutation group compared to *HAX1* or unknown mutation group.

In GCF, elevated levels of both HNP1--3 and LL-37 have been reported in subjects with chronic periodontitis, most likely due to enhanced neutrophil influx \[[@CR32]\]. In our study, the GCF levels of HNP1--3 and LL-37 did not appear to be statistically different between patients harboring different mutations, possibly due to the wide range of values in both groups. The α-defensins HNP1--3 are stored in primary granules in neutrophils, and the GCF levels of HNP1--3 have been reported to vary widely in healthy subjects \[[@CR33], [@CR34]\]. The considerable difference of GCF HNP1--3 in the present study is compatible with our previous observation that HNP1--3 levels vary from deficiency to normal levels in neutrophils from patients with SCN \[[@CR14]\]. To date, gingival LL-37 has been demonstrated to have two main sites of origin, neutrophils and epithelial cells \[[@CR35]\]. In the absence of neutrophil-derived LL-37 in the GCF of patients with SCN, it was possible to determine the epithelial contribution to LL-37 levels, which was found to be noticeably low. LL-37 levels below bactericidal concentrations have been demonstrated to serve as a chemoattractant or modulator of host inflammatory responses in concert with other epithelial-derived cytokines \[[@CR36]--[@CR38]\]. Thus, in the absence of efficient neutrophil antibacterial clearance due to deficiency of neutrophil granule peptides, epithelial-derived peptides might even augment periodontal inflammation.

In the current study, we demonstrated that IL-1β levels were significantly higher in GCF samples from subjects with mutant *ELANE*. In addition, the mean and median levels of IL-17, IL-6, and TNF-α in patients with *ELANE* mutations were higher than in *HAX1* or unknown mutations although these differences did not reach statistical significance, most likely due to the small size of the cohort and great variations within groups. It is known that elevated levels of IL-1β \[[@CR39], [@CR40]\], IL-6 \[[@CR41]\], TNF-α \[[@CR42]\], and IL-17 \[[@CR43]\] in GCF are associated with severe periodontal disease, and that these cytokines may also be elevated in chronic periodontitis tissue \[[@CR44]--[@CR46]\]. Thus, the GCF from patients with *ELANE* mutations displays the presence of the strong proinflammatory cytokine IL-1β, which might be expected in the inflamed periodontium.

Oral microbiota in the healthy population has been determined using high-throughput 16S rDNA pyrosequencing in several studies \[[@CR47]--[@CR49]\], providing a rather comprehensive view of the oral commensal microbial community. To our knowledge, this is the first time that the 16S rDNA pyrosequencing technique has been employed to map subgingival microbiota in subjects with a congenital immunodeficiency. The predominant taxa from periodontal sites of individuals with SCN were similar to the microbiota previously reported from healthy subjects \[[@CR49]\]. Although two patients with *ELANE* mutations were not included in microbiota analyses due to edentulism, hierarchical clustering and UniFrac PCoA analysis revealed that three out of four samples from the *ELANE* mutation group were clustered with the periodontitis reference individuals. The skewed periodontal microbiota in both periodontitis references and the *ELANE* mutation group of SCN cases indicates that periodontal pathogens of the genera Fusobacterium, Prevotella, Treponema, and TM7 domain are more likely to grow in the gingival crevices in patients with *ELANE* mutations compared to *HAX1* or unknown mutations \[[@CR50]\]. As an outlier, PN2 did not cluster with other individuals with *ELANE* mutations that may partly be explained by the fact that periodontal pathogens of young children may differ from those of adolescent or adults \[[@CR51], [@CR52]\].

The neutropenia of patients with SCN arises as a consequence of bone marrow neutrophil precursor accelerated apoptosis \[[@CR53]\]. The two most frequently reported gene mutations of SCN are *HAX1* and *ELANE* \[[@CR54]\]. HAX-1 is a mitochondrial protein involved in maintaining the mitochondrial membrane potential, signal transduction, and cell survival \[[@CR55], [@CR56]\]. The *HAX1* mutations in SCN result in HAX-1-deficient neutrophils and neutrophil precursors, which have been demonstrated to show enhanced apoptosis \[[@CR57]\]. The mechanism by which *ELANE* mutations result in apoptosis of neutrophil precursors is less obvious, but it has been suggested that the accumulation of misfolded elastase proteins activates the unfolded protein response, leading to apoptosis \[[@CR58], [@CR59]\]. Although rescued by G-CSF treatment, the neutrophils with *ELANE* mutations still carry mutated elastase proteins that may be aberrant in their localization and functions such as proteolytic processing of other proenzymes or cytokines, which in turn may affect the local periodontal immune response \[[@CR60]\]. Thus, it is possible that in addition to the antimicrobial peptide deficiency that is shared by all patients with SCN, the *ELANE* mutations may confer an additional neutrophil dysfunctionality, leading to more severe periodontal disease.

Conclusion {#Sec14}
==========

We herein report that patients with SCN that harbor mutations in the gene *ELANE* coding for neutrophil elastase present with more severe periodontal disease as compared to patients with *HAX1* mutations or with unknown mutations. The periodontal pockets of the former group display a skewed microflora and elevated levels of proinflammatory cytokine IL-1β. The correlation between *ELANE* mutations and periodontal disease indicates that the serine protease elastase may have an important role in the local defense in the gingival pocket.
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